FLSM
Frazier Life Sciences Management’s Edgewise Therapeutics EWTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,271,245
| Closed | -$33.9M | – | 53 |
|
|
2024
Q4 | $33.9M | Sell |
1,271,245
-1,561,622
| -55% | -$41.7M | 1.41% | 18 |
|
|
2024
Q3 | $75.6M | Sell |
2,832,867
-898,200
| -24% | -$24M | 3.03% | 12 |
|
|
2024
Q2 | $67.2M | Buy |
3,731,067
+427,500
| +13% | +$7.7M | 3.14% | 11 |
|
|
2024
Q1 | $60.3M | Buy |
3,303,567
+636,364
| +24% | +$11.6M | 2.54% | 12 |
|
|
2023
Q4 | $29.2M | Buy |
2,667,203
+1,818,181
| +214% | +$19.9M | 1.56% | 16 |
|
|
2023
Q3 | $4.86M | Buy |
849,022
+100,000
| +13% | +$573K | 0.32% | 44 |
|
|
2023
Q2 | $5.8M | Buy |
749,022
+66,561
| +10% | +$516K | 0.35% | 38 |
|
|
2023
Q1 | $4.55M | Buy |
+682,461
| New | +$4.55M | 0.33% | 44 |
|